Pure Bioscience Top Management
Pure Bioscience employs about 15 people. The company is managed by 5 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 3.0 employees per reported executive. Evaluation of Pure Bioscience's management performance can provide insight into the firm performance.
| Tom CPA Insider Pres CEO |
| Thomas Myers Insider COO Director |
Pure |
Pure Bioscience Management Team Effectiveness
The company has return on total asset (ROA) of (0.6231) % which means that it has lost $0.6231 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2879) %, meaning that it created substantial loss on money invested by shareholders. Pure Bioscience's management efficiency ratios could be used to measure how well Pure Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Pure Bioscience Workforce Comparison
Pure Bioscience is regarded fifth in number of employees category among its peers. The total workforce of Consumer Staples industry is at this time estimated at about 123,435. Pure Bioscience adds roughly 15.0 in number of employees claiming only tiny portion of stocks in Consumer Staples industry.
The company has Profit Margin (PM) of (2.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.98) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.98. Pure Bioscience Notable Stakeholders
A Pure Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pure Bioscience often face trade-offs trying to please all of them. Pure Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pure Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mark Elliott | Principal Financial and Accounting Officer and VP of Fin. | Profile | |
| Tom CPA | Pres CEO | Profile | |
| Thomas Myers | COO Director | Profile | |
| John Kasperski | VP Sales | Profile | |
| Zhinong Yan | Exec Devel | Profile |
Pure Bioscience Workforce Analysis
Traditionally, organizations such as Pure Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pure Bioscience within its industry.Pure Bioscience Manpower Efficiency
Return on Pure Bioscience Manpower
| Revenue Per Employee | 123.5K | |
| Revenue Per Executive | 370.6K | |
| Net Loss Per Employee | 232.7K | |
| Net Loss Per Executive | 698.2K | |
| Working Capital Per Employee | 240.4K | |
| Working Capital Per Executive | 721.2K |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Pure Pink Sheet
If you are still planning to invest in Pure Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pure Bioscience's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |